While our study demonstrates the independent associations of MDA-LDL and CRP with PAS in HD patients, further cohort studies with larger sample sizes and clinical trials are needed to evaluate the potential therapeutic implications of the findings to develop effective strategies for reducing CVD in this vulnerable population. The gene discussed is CRP; the disease is Huntington disease.